{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:19:10Z","timestamp":1792790350152,"version":"4.5.0"},"posted":{"date-parts":[[2026,9,12]]},"group-title":"Infectious Diseases (except HIV\/AIDS)","reference-count":32,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"award":["75D30121C12879"],"award-info":[{"award-number":["75D30121C12879"]}],"id":[{"id":"https:\/\/ror.org\/042twtr12","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Swiss National Science Foundation","award":["214129"],"award-info":[{"award-number":["214129"]}],"id":[{"id":"https:\/\/ror.org\/00yjd3n13","id-type":"ROR","asserted-by":"crossref"}]},{"award":["P30AI168440"],"award-info":[{"award-number":["P30AI168440"]}],"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"publisher"}]},{"award":["1R25AI147375"],"award-info":[{"award-number":["1R25AI147375"]}],"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"publisher"}]},{"name":"National Institutes of Health","award":["P30AI027763"],"award-info":[{"award-number":["P30AI027763"]}]},{"award":["UL1TR001872"],"award-info":[{"award-number":["UL1TR001872"]}],"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,9,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Despite efforts to eliminate tuberculosis (TB) in the United States (U.S.), many individuals diagnosed with latent TB infection (LTBI) who are at increased risk of progressing to TB disease do not initiate TB preventive treatment.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Among adults receiving primary care in a federally qualified community health center in the San Francisco Bay Area, California, we conducted a cross-sectional online survey using a situational choice experiment to assess the circumstances in which individuals at risk for TB based on nativity would accept LTBI treatment. In 10 randomized choice tasks, participants answered whether or not they would accept LTBI treatment. In situations where LTBI treatment was accepted, participants were asked a follow-up question about whether they would change their response knowing that reinfection is still possible with LTBI treatment. Attributes assessed included risk level of progression to TB, side effects, changes to co-medication, cost, number of clinic visits, blood draws, and reinfection risk. We conducted a mixed-effects logistic regression to estimate factors associated with treatment acceptance and predicted acceptance across scenarios.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 852 individuals who consented, 458 (53.8%) had complete responses and were included in the analysis. LTBI treatment was accepted in 69.4% of choice scenarios (3180\/4580); among scenarios where treatment was initially accepted, 91.5% of scenarios (2911\/3180) remained accepted when reinfection possibility was introduced. Compared to situations with low risk of TB progression, high TB progression risk increased the acceptance of LTBI treatment (adjusted odds ratio aOR 2.55, 95% Confidence Interval (CI) = 2.03\u20133.19). Compared with fatigue as a referent, risk of any liver injury\/inflammation (aOR 0.29, 95% CI = 0.22\u20130.38), gastrointestinal side effects (aOR 0.53, 95% CI 0.41, 0.69), rash (aOR 0.62, 95% CI 0.48-0.80) and out-of-pocket cost of $100 (aOR 0.32, 95% CI = 0.26\u20130.41 compared to $0) were associated with lower acceptance of LTBI treatment.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The decision to accept LTBI treatment was sensitive to treatment characteristics, suggesting that shared decision-making should be broadly promoted among individuals diagnosed with or at risk of LTBI, particularly in diverse primary care settings serving individuals born in high TB burden countries, with attention to individual concerns such as cost and side effects to improve LTBI treatment uptake.<\/jats:p>\n                <\/jats:sec>","DOI":"10.64898\/2026.09.09.26362665","type":"posted-content","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T23:35:11Z","timestamp":1789256111000},"source":"Crossref","is-referenced-by-count":0,"title":["Factors associated with a willingness to accept latent tuberculosis infection treatment among non-U.S.\u2013born individuals: a situational choice experiment"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-3556-0832","authenticated-orcid":false,"given":"Sutina","family":"Chou","sequence":"first","affiliation":[{"name":"Institute for Health & Aging, Department of Social and Behavioral Sciences, University of California San Francisco School of Nursing, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne E.","family":"Aschmann","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, CA"},{"name":"Center for Tuberculosis, University of California San Francisco, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S.","family":"Tang","sequence":"additional","affiliation":[{"name":"North East Medical Services, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meagan","family":"Lee","sequence":"additional","affiliation":[{"name":"North East Medical Services, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zinnia","family":"Dong","sequence":"additional","affiliation":[{"name":"North East Medical Services, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kit","family":"Lui","sequence":"additional","affiliation":[{"name":"North East Medical Services, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqian","family":"Ouyang","sequence":"additional","affiliation":[{"name":"North East Medical Services, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Chen","sequence":"additional","affiliation":[{"name":"North East Medical Services, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katya L.","family":"Salcedo","sequence":"additional","affiliation":[{"name":"Institute for Global Health Sciences, University of California San Francisco, San Francisco"},{"name":"Tuberculosis Control Branch, California Department of Public Health, Richmond, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Murrill","sequence":"additional","affiliation":[{"name":"Center for Tuberculosis, University of California San Francisco, San Francisco, CA;"},{"name":"Division of Hospital Medicine, University of California San Francisco, San Francisco, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7783-1289","authenticated-orcid":false,"given":"Mehabuba","family":"Rahman","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Flood","sequence":"additional","affiliation":[{"name":"Tuberculosis Control Branch, California Department of Public Health, Richmond, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5023-6658","authenticated-orcid":false,"given":"Andrew D.","family":"Kerkhoff","sequence":"additional","affiliation":[{"name":"Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya B.","family":"Shete","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, CA"},{"name":"Center for Tuberculosis, University of California San Francisco, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy Kuo","family":"Lin","sequence":"additional","affiliation":[{"name":"Institute for Health & Aging, Department of Social and Behavioral Sciences, University of California San Francisco School of Nursing, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Tuberculosis Epidemiologic Studies Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026091611200604000_2026.09.09.26362665v1.1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwt246"},{"key":"2026091611200604000_2026.09.09.26362665v1.2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0153728"},{"key":"2026091611200604000_2026.09.09.26362665v1.3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m549"},{"key":"2026091611200604000_2026.09.09.26362665v1.4","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v43i34a01"},{"key":"2026091611200604000_2026.09.09.26362665v1.5","unstructured":"Price C , Nguyen AD. Latent Tuberculosis. In: StatPearls. Treasure Island (FL): StatPearls Publishing, http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK599527\/ (2026, accessed 1 July 2026)."},{"key":"2026091611200604000_2026.09.09.26362665v1.6","unstructured":"CDC. Tuberculosis Elimination Priorities. National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention, https:\/\/www.cdc.gov\/nchhstp\/priorities\/tuberculosis-elimination.html (2024, accessed 7 January 2026)."},{"key":"2026091611200604000_2026.09.09.26362665v1.7","doi-asserted-by":"publisher","DOI":"10.7326\/M17-0609"},{"key":"2026091611200604000_2026.09.09.26362665v1.8","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(19)30575-4","article-title":"Adverse events in adults with latent tuberculosis infection receiving daily rifampicin or isoniazid: post-hoc safety analysis of two randomised controlled trials","volume":"20","year":"2020","journal-title":"The Lancet Infectious Diseases"},{"key":"2026091611200604000_2026.09.09.26362665v1.9","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/ajt.15841","article-title":"Guidelines for the treatment of latent tuberculosis infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020","volume":"20","year":"2020","journal-title":"American Journal of Transplantation"},{"key":"2026091611200604000_2026.09.09.26362665v1.10","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1093\/cid\/ciac248","article-title":"Evaluation of the Latent Tuberculosis Care Cascade Among Public Health Clinics in the United States","volume":"75","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2026091611200604000_2026.09.09.26362665v1.11","doi-asserted-by":"crossref","unstructured":"Vonnahme LA , Raykin J , Jones M , et al. Using Electronic Health Record Data to Measure the Latent Tuberculosis Infection Care Cascade in Safety-Net Primary Care Clinics. AJPM Focus 2023; 2: 100148.","DOI":"10.1016\/j.focus.2023.100148"},{"key":"2026091611200604000_2026.09.09.26362665v1.12","unstructured":"Aschmann HE , Tang A , Lee M , et al. Preferences for Tuberculosis Preventive Therapy in Primary Care Settings Among At-risk Immigrant Communities. In: 2024 Annual Meeting of the Society of General Internal Medicine. Springer, p. S798."},{"key":"2026091611200604000_2026.09.09.26362665v1.13","doi-asserted-by":"crossref","first-page":"ofaf589","DOI":"10.1093\/ofid\/ofaf589","article-title":"Identifying Gaps in Tuberculosis Preventive Care for Non-U.S.-born Persons at Community Health Clinics in the United States","volume":"12","year":"2025","journal-title":"Open Forum Infectious Diseases"},{"key":"2026091611200604000_2026.09.09.26362665v1.14","doi-asserted-by":"crossref","first-page":"e26390","DOI":"10.1002\/jia2.26390","article-title":"Preferences of people living with HIV for features of tuberculosis preventive treatment regimens in Uganda: a discrete choice experiment","volume":"27","year":"2024","journal-title":"J Int AIDS Soc"},{"key":"2026091611200604000_2026.09.09.26362665v1.15","doi-asserted-by":"crossref","first-page":"276","DOI":"10.5588\/ijtldopen.24.0670","article-title":"Patient and provider preferences for long-acting TB preventive therapy","volume":"2","year":"2025","journal-title":"IJTLD Open"},{"key":"2026091611200604000_2026.09.09.26362665v1.16","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-048443"},{"key":"2026091611200604000_2026.09.09.26362665v1.17","doi-asserted-by":"crossref","first-page":"520","DOI":"10.5588\/ijtld.22.0645","article-title":"TB preventive therapy preferences among children and adolescents","volume":"27","year":"2023","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026091611200604000_2026.09.09.26362665v1.18","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jval.2017.04.007","article-title":"Testing the External Validity of a Discrete Choice Experiment Method: An Application to Latent Tuberculosis Infection Treatment","volume":"20","year":"2017","journal-title":"Value in Health"},{"key":"2026091611200604000_2026.09.09.26362665v1.19","unstructured":"World Health Organization. Global Tuberculosis Report 2025, https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/tb-reports\/global-tuberculosis-report-2025 (12 November 2025, accessed 9 January 2026)."},{"key":"2026091611200604000_2026.09.09.26362665v1.20","unstructured":"Chrzan K. Situational Choice Experiments for Marketing Research: How to Design, Analyze and Report Them. Sawtooth Software, Inc., https:\/\/content.sawtoothsoftware.com\/assets\/c6112de1-d968-4754-a271-fab97555e831 (November 2022)."},{"key":"2026091611200604000_2026.09.09.26362665v1.21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11606-024-08797-5","article-title":"Abstracts from the 2024 Annual Meeting of the Society of General Internal Medicine","volume":"39","year":"2024","journal-title":"J GEN INTERN MED"},{"key":"2026091611200604000_2026.09.09.26362665v1.22","unstructured":"Sawtooth Software, Inc. The CBC System for Choice-Based Conjoint Analysis. Sawtooth Software, Inc., https:\/\/sawtoothsoftware.com\/resources\/technical-papers\/cbc-technical-paper (August 2017, accessed 31 March 2025)."},{"key":"2026091611200604000_2026.09.09.26362665v1.23","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(96)00236-3"},{"key":"2026091611200604000_2026.09.09.26362665v1.24","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v067.i01"},{"key":"2026091611200604000_2026.09.09.26362665v1.25","first-page":"803","article-title":"Can Primary Care Drive Tuberculosis Elimination?","volume":"25","year":"2023","journal-title":"Increasing Latent Tuberculosis Infection Testing and Treatment Initiation at a Community Health Center with a Large Non-U.S.-born Population. J Immigrant Minority Health"},{"key":"2026091611200604000_2026.09.09.26362665v1.26","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1513\/AnnalsATS.202009-1153OC","article-title":"Self-reported Engagement in Care among U.S. Residents with Latent Tuberculosis Infection: 2011\u20132012","volume":"18","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"2026091611200604000_2026.09.09.26362665v1.27","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jval.2011.05.003","article-title":"Patient Preference for Latent Tuberculosis Infection Preventive Treatment: A Discrete Choice Experiment","volume":"14","year":"2011","journal-title":"Value in Health"},{"key":"2026091611200604000_2026.09.09.26362665v1.28","doi-asserted-by":"crossref","unstructured":"Aschmann HE , Musinguzi A , Kadota JL , et al. Preferences of people living with HIV for features of tuberculosis preventive treatment regimens \u2013 a discrete choice experiment. medRxiv 2023; 2023.09.13.23295043.","DOI":"10.1101\/2023.09.13.23295043"},{"key":"2026091611200604000_2026.09.09.26362665v1.29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.5588\/ijtldopen.23.0283","article-title":"Preference for daily (1HP) vs. weekly (3HP) isoniazid-rifapentine among people living with HIV in Uganda","volume":"1","year":"2024","journal-title":"IJTLD OPEN"},{"key":"2026091611200604000_2026.09.09.26362665v1.30","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.6.716"},{"key":"2026091611200604000_2026.09.09.26362665v1.31","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.5588\/ijtld.10.0447","article-title":"The Innovative Socio-economic Interventions Against Tuberculosis (ISIAT) project: an operational assessment","volume":"15","year":"2011","journal-title":"The International Journal of Tuberculosis and Lung Disease"},{"key":"2026091611200604000_2026.09.09.26362665v1.32","doi-asserted-by":"crossref","first-page":"100","DOI":"10.5588\/ijtld.19.0185","article-title":"Interventions to reduce losses in the cascade of care for latent tuberculosis: a systematic review and meta-analysis","volume":"24","year":"2020","journal-title":"The International Journal of Tuberculosis and Lung Disease"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.09.09.26362665","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:20:20Z","timestamp":1789582820000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.64898\/2026.09.09.26362665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,12]]},"references-count":32,"URL":"https:\/\/doi.org\/10.64898\/2026.09.09.26362665","relation":{},"subject":[],"published":{"date-parts":[[2026,9,12]]},"subtype":"preprint"}}